 Swati Patel
Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 44 | 2026 | 868 | 10.950 |
Why?
| | Colonoscopy | 32 | 2025 | 264 | 7.770 |
Why?
| | Early Detection of Cancer | 23 | 2025 | 486 | 6.180 |
Why?
| | Colonic Polyps | 13 | 2025 | 88 | 5.810 |
Why?
| | Gastroenterology | 12 | 2025 | 191 | 4.240 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 6 | 2026 | 41 | 3.210 |
Why?
| | Clinical Competence | 12 | 2025 | 1247 | 2.270 |
Why?
| | Mass Screening | 14 | 2025 | 1361 | 1.920 |
Why?
| | Adenomatous Polyps | 3 | 2020 | 9 | 1.710 |
Why?
| | Adenoma | 5 | 2024 | 218 | 1.250 |
Why?
| | Intestinal Polyposis | 4 | 2022 | 7 | 1.130 |
Why?
| | Adenocarcinoma | 5 | 2022 | 926 | 1.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2025 | 1420 | 1.060 |
Why?
| | Incidence | 12 | 2026 | 2934 | 1.000 |
Why?
| | Narrow Band Imaging | 3 | 2019 | 14 | 0.990 |
Why?
| | Neoplastic Syndromes, Hereditary | 5 | 2026 | 47 | 0.970 |
Why?
| | Precancerous Conditions | 2 | 2021 | 166 | 0.960 |
Why?
| | Age of Onset | 7 | 2026 | 557 | 0.950 |
Why?
| | Endoscopy, Digestive System | 3 | 2020 | 142 | 0.940 |
Why?
| | Helminthiasis | 1 | 2025 | 11 | 0.890 |
Why?
| | Anthelmintics | 1 | 2025 | 12 | 0.890 |
Why?
| | Helminths | 1 | 2025 | 11 | 0.890 |
Why?
| | Biological Evolution | 3 | 2025 | 468 | 0.880 |
Why?
| | Risk Assessment | 6 | 2022 | 3752 | 0.860 |
Why?
| | Humans | 80 | 2026 | 145783 | 0.860 |
Why?
| | Competency-Based Education | 2 | 2015 | 81 | 0.840 |
Why?
| | Drug Resistance | 1 | 2025 | 145 | 0.840 |
Why?
| | Self-Assessment | 1 | 2025 | 74 | 0.830 |
Why?
| | Appendiceal Neoplasms | 2 | 2022 | 28 | 0.820 |
Why?
| | Risk Factors | 15 | 2026 | 10919 | 0.800 |
Why?
| | Soil | 1 | 2025 | 147 | 0.800 |
Why?
| | Mobile Applications | 1 | 2025 | 199 | 0.750 |
Why?
| | Occult Blood | 4 | 2025 | 40 | 0.700 |
Why?
| | Fellowships and Scholarships | 3 | 2021 | 354 | 0.700 |
Why?
| | Crassostrea | 1 | 2021 | 1 | 0.700 |
Why?
| | Gills | 1 | 2021 | 6 | 0.700 |
Why?
| | Petroleum Pollution | 1 | 2021 | 11 | 0.690 |
Why?
| | Societies, Medical | 2 | 2026 | 900 | 0.680 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2022 | 62 | 0.670 |
Why?
| | Cathartics | 3 | 2025 | 15 | 0.660 |
Why?
| | Aftercare | 1 | 2023 | 222 | 0.660 |
Why?
| | Utilization Review | 1 | 2020 | 39 | 0.630 |
Why?
| | Hamartoma Syndrome, Multiple | 4 | 2022 | 16 | 0.630 |
Why?
| | Genes, APC | 1 | 2020 | 11 | 0.630 |
Why?
| | Education, Medical, Graduate | 2 | 2015 | 562 | 0.620 |
Why?
| | Middle Aged | 25 | 2026 | 36309 | 0.620 |
Why?
| | Intestinal Polyps | 4 | 2022 | 14 | 0.610 |
Why?
| | Hospitals, Veterans | 1 | 2020 | 258 | 0.570 |
Why?
| | Gastrointestinal Tract | 1 | 2021 | 204 | 0.570 |
Why?
| | Stomach Neoplasms | 1 | 2020 | 128 | 0.540 |
Why?
| | Peutz-Jeghers Syndrome | 3 | 2022 | 10 | 0.540 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 14 | 0.540 |
Why?
| | Curriculum | 2 | 2015 | 1074 | 0.540 |
Why?
| | Genetic Testing | 3 | 2022 | 483 | 0.540 |
Why?
| | Genetic Predisposition to Disease | 7 | 2026 | 2399 | 0.530 |
Why?
| | Hamartoma | 3 | 2022 | 29 | 0.530 |
Why?
| | Surgeons | 1 | 2022 | 340 | 0.520 |
Why?
| | Patient Discharge | 2 | 2023 | 995 | 0.510 |
Why?
| | Adult | 22 | 2026 | 40881 | 0.500 |
Why?
| | Practice Guidelines as Topic | 3 | 2022 | 1582 | 0.500 |
Why?
| | Quality Assurance, Health Care | 1 | 2019 | 342 | 0.490 |
Why?
| | United States | 17 | 2026 | 16126 | 0.490 |
Why?
| | Learning Curve | 4 | 2024 | 71 | 0.490 |
Why?
| | Guideline Adherence | 1 | 2020 | 587 | 0.460 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2023 | 138 | 0.450 |
Why?
| | Genetic Counseling | 1 | 2016 | 80 | 0.450 |
Why?
| | Female | 30 | 2026 | 79045 | 0.420 |
Why?
| | Age Factors | 6 | 2022 | 3346 | 0.420 |
Why?
| | Male | 28 | 2026 | 73011 | 0.420 |
Why?
| | Ecosystem | 2 | 2020 | 478 | 0.410 |
Why?
| | Predictive Value of Tests | 4 | 2021 | 2123 | 0.410 |
Why?
| | North America | 2 | 2026 | 304 | 0.390 |
Why?
| | Polyps | 1 | 2013 | 14 | 0.380 |
Why?
| | DNA Glycosylases | 1 | 2012 | 10 | 0.370 |
Why?
| | Models, Biological | 1 | 2017 | 1764 | 0.310 |
Why?
| | Life Style | 2 | 2026 | 486 | 0.310 |
Why?
| | Formative Feedback | 2 | 2024 | 36 | 0.310 |
Why?
| | Prospective Studies | 6 | 2026 | 8078 | 0.300 |
Why?
| | Education, Medical | 1 | 2013 | 276 | 0.300 |
Why?
| | Aged | 10 | 2026 | 26217 | 0.260 |
Why?
| | Mutation | 4 | 2024 | 4090 | 0.250 |
Why?
| | Benchmarking | 2 | 2020 | 191 | 0.240 |
Why?
| | Phytochemicals | 1 | 2026 | 13 | 0.240 |
Why?
| | Fetal Proteins | 1 | 2026 | 15 | 0.240 |
Why?
| | Mucin-1 | 1 | 2026 | 21 | 0.240 |
Why?
| | Carcinoembryonic Antigen | 1 | 2026 | 40 | 0.240 |
Why?
| | Oryza | 1 | 2026 | 32 | 0.240 |
Why?
| | Dietary Fiber | 1 | 2026 | 59 | 0.230 |
Why?
| | Anesthesiology | 1 | 2009 | 179 | 0.230 |
Why?
| | T-Box Domain Proteins | 1 | 2026 | 106 | 0.230 |
Why?
| | Feces | 2 | 2026 | 496 | 0.230 |
Why?
| | Aged, 80 and over | 4 | 2021 | 8347 | 0.220 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2026 | 73 | 0.220 |
Why?
| | Wiskott-Aldrich Syndrome Protein | 1 | 2024 | 4 | 0.220 |
Why?
| | Singapore | 1 | 2025 | 27 | 0.220 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2024 | 5 | 0.220 |
Why?
| | Life Cycle Stages | 1 | 2025 | 37 | 0.220 |
Why?
| | Cancer Vaccines | 1 | 2026 | 163 | 0.210 |
Why?
| | Gene-Environment Interaction | 1 | 2026 | 180 | 0.210 |
Why?
| | Multicenter Studies as Topic | 1 | 2026 | 413 | 0.210 |
Why?
| | Trust | 1 | 2025 | 158 | 0.200 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2024 | 92 | 0.200 |
Why?
| | Computer-Assisted Instruction | 1 | 2024 | 70 | 0.190 |
Why?
| | Recombinant Fusion Proteins | 1 | 2026 | 666 | 0.190 |
Why?
| | Carcinoid Tumor | 1 | 2022 | 21 | 0.190 |
Why?
| | Calcitriol | 1 | 2022 | 58 | 0.180 |
Why?
| | Drug Monitoring | 1 | 2026 | 401 | 0.180 |
Why?
| | Surgical Instruments | 1 | 2022 | 51 | 0.180 |
Why?
| | Ecotoxicology | 1 | 2021 | 3 | 0.170 |
Why?
| | Educational Measurement | 1 | 2025 | 326 | 0.170 |
Why?
| | Trypanosomiasis, African | 1 | 2021 | 2 | 0.170 |
Why?
| | Metaplasia | 1 | 2021 | 57 | 0.170 |
Why?
| | Neoplasms | 3 | 2023 | 2913 | 0.170 |
Why?
| | Alleles | 3 | 2022 | 896 | 0.170 |
Why?
| | Simethicone | 3 | 2025 | 5 | 0.170 |
Why?
| | Stomach | 1 | 2021 | 111 | 0.170 |
Why?
| | Europe | 1 | 2022 | 421 | 0.170 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2026 | 364 | 0.170 |
Why?
| | Preventive Medicine | 1 | 2021 | 39 | 0.170 |
Why?
| | Sensitivity and Specificity | 2 | 2024 | 2000 | 0.160 |
Why?
| | Documentation | 1 | 2023 | 199 | 0.160 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2023 | 237 | 0.160 |
Why?
| | Pediatrics | 1 | 2009 | 1125 | 0.160 |
Why?
| | Colonic Neoplasms | 1 | 2022 | 258 | 0.160 |
Why?
| | Video Recording | 2 | 2019 | 219 | 0.160 |
Why?
| | Endoscopy | 1 | 2022 | 317 | 0.150 |
Why?
| | Carcinoma | 1 | 2021 | 227 | 0.150 |
Why?
| | Research Design | 1 | 2026 | 1139 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2022 | 440 | 0.150 |
Why?
| | Consensus | 1 | 2021 | 479 | 0.150 |
Why?
| | Diarrhea | 1 | 2020 | 193 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2024 | 381 | 0.150 |
Why?
| | Smoking | 1 | 2026 | 1477 | 0.140 |
Why?
| | Syndrome | 1 | 2020 | 381 | 0.140 |
Why?
| | Alcohol Drinking | 1 | 2026 | 843 | 0.140 |
Why?
| | Accreditation | 2 | 2020 | 101 | 0.140 |
Why?
| | Environmental Monitoring | 1 | 2021 | 347 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 1 | 2026 | 883 | 0.140 |
Why?
| | Water Pollutants, Chemical | 1 | 2021 | 227 | 0.140 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 364 | 0.130 |
Why?
| | Vincristine | 1 | 2018 | 144 | 0.130 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 81 | 0.130 |
Why?
| | Qualitative Research | 1 | 2025 | 1683 | 0.130 |
Why?
| | Congresses as Topic | 1 | 2019 | 224 | 0.130 |
Why?
| | Mathematical Concepts | 1 | 2017 | 35 | 0.130 |
Why?
| | Immunomodulation | 1 | 2018 | 99 | 0.130 |
Why?
| | Feedback, Physiological | 1 | 2017 | 80 | 0.130 |
Why?
| | Risk | 2 | 2020 | 923 | 0.130 |
Why?
| | Health Literacy | 1 | 2020 | 186 | 0.130 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2018 | 134 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2025 | 1197 | 0.130 |
Why?
| | Young Adult | 3 | 2025 | 14254 | 0.130 |
Why?
| | Delphi Technique | 1 | 2019 | 333 | 0.130 |
Why?
| | Portal Vein | 1 | 2018 | 117 | 0.130 |
Why?
| | Animals | 5 | 2025 | 38102 | 0.130 |
Why?
| | Population Dynamics | 1 | 2017 | 142 | 0.120 |
Why?
| | Bile Duct Neoplasms | 1 | 2018 | 131 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 644 | 0.120 |
Why?
| | Telemedicine | 1 | 2025 | 967 | 0.120 |
Why?
| | Genetic Association Studies | 1 | 2017 | 371 | 0.120 |
Why?
| | Phenotype | 2 | 2024 | 3170 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1512 | 0.110 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1247 | 0.110 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 297 | 0.110 |
Why?
| | Retrospective Studies | 3 | 2026 | 17330 | 0.110 |
Why?
| | Program Evaluation | 2 | 2020 | 944 | 0.110 |
Why?
| | Patient Education as Topic | 1 | 2020 | 777 | 0.110 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2014 | 214 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 195 | 0.100 |
Why?
| | Colorectal Surgery | 1 | 2014 | 30 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 198 | 0.100 |
Why?
| | Prevalence | 1 | 2021 | 2875 | 0.100 |
Why?
| | Electronic Health Records | 1 | 2022 | 1202 | 0.100 |
Why?
| | Early Diagnosis | 1 | 2015 | 251 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1180 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 977 | 0.100 |
Why?
| | Image Enhancement | 1 | 2014 | 200 | 0.100 |
Why?
| | Histocytochemistry | 1 | 2013 | 78 | 0.100 |
Why?
| | Primary Prevention | 1 | 2015 | 222 | 0.090 |
Why?
| | Odds Ratio | 1 | 2015 | 1083 | 0.090 |
Why?
| | Obesity | 1 | 2026 | 3118 | 0.090 |
Why?
| | Magnetic Resonance Angiography | 1 | 2014 | 251 | 0.090 |
Why?
| | Data Collection | 1 | 2015 | 643 | 0.090 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1547 | 0.090 |
Why?
| | Cell Adhesion Molecules | 1 | 2012 | 181 | 0.090 |
Why?
| | SEER Program | 2 | 2022 | 230 | 0.080 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1329 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3418 | 0.080 |
Why?
| | Internship and Residency | 1 | 2021 | 1269 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2139 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 928 | 0.080 |
Why?
| | Health Promotion | 1 | 2016 | 775 | 0.070 |
Why?
| | Veterans | 1 | 2021 | 1642 | 0.070 |
Why?
| | Organization and Administration | 1 | 2009 | 14 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1969 | 0.070 |
Why?
| | Analgesia | 1 | 2009 | 106 | 0.070 |
Why?
| | Anesthesia, General | 1 | 2009 | 121 | 0.070 |
Why?
| | Monitoring, Physiologic | 1 | 2009 | 289 | 0.060 |
Why?
| | Functional Food | 1 | 2026 | 4 | 0.060 |
Why?
| | Phenylpropionates | 1 | 2026 | 27 | 0.060 |
Why?
| | Nutritive Value | 1 | 2026 | 41 | 0.060 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 910 | 0.060 |
Why?
| | Prebiotics | 1 | 2026 | 28 | 0.060 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2026 | 41 | 0.060 |
Why?
| | Vaccines, Synthetic | 1 | 2026 | 137 | 0.060 |
Why?
| | Adenoviridae | 1 | 2026 | 199 | 0.060 |
Why?
| | History, 21st Century | 1 | 2026 | 222 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2004 | 6 | 0.050 |
Why?
| | History, 20th Century | 1 | 2026 | 328 | 0.050 |
Why?
| | India | 1 | 2024 | 213 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2024 | 410 | 0.050 |
Why?
| | Surgery, Plastic | 1 | 2004 | 53 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2026 | 423 | 0.050 |
Why?
| | Skull | 1 | 2004 | 163 | 0.050 |
Why?
| | Receptors, CCR7 | 1 | 2022 | 32 | 0.050 |
Why?
| | Microsurgery | 1 | 2023 | 76 | 0.050 |
Why?
| | Antioxidants | 1 | 2026 | 550 | 0.050 |
Why?
| | Child | 4 | 2024 | 22740 | 0.050 |
Why?
| | Biological Products | 1 | 2026 | 257 | 0.040 |
Why?
| | Appendectomy | 1 | 2022 | 90 | 0.040 |
Why?
| | Trypanosoma brucei gambiense | 1 | 2021 | 1 | 0.040 |
Why?
| | Oncogenes | 1 | 2022 | 118 | 0.040 |
Why?
| | Democratic Republic of the Congo | 1 | 2021 | 33 | 0.040 |
Why?
| | Methotrexate | 1 | 2022 | 233 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2026 | 2064 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5925 | 0.040 |
Why?
| | Liposomes | 1 | 2022 | 263 | 0.040 |
Why?
| | Probability | 1 | 2021 | 308 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 260 | 0.040 |
Why?
| | Patient Preference | 1 | 2022 | 223 | 0.040 |
Why?
| | Rectal Neoplasms | 1 | 2021 | 159 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 457 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 383 | 0.040 |
Why?
| | Feedback | 1 | 2019 | 180 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 673 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 667 | 0.040 |
Why?
| | Infant | 3 | 2024 | 10091 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2017 | 22 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2022 | 480 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2018 | 224 | 0.030 |
Why?
| | Algorithms | 1 | 2026 | 1851 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2022 | 1475 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 668 | 0.030 |
Why?
| | Codon | 1 | 2017 | 92 | 0.030 |
Why?
| | Exome | 1 | 2018 | 229 | 0.030 |
Why?
| | Peptides | 1 | 2022 | 999 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2018 | 420 | 0.030 |
Why?
| | Health Status Disparities | 1 | 2019 | 321 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 981 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1115 | 0.030 |
Why?
| | Hospitalization | 1 | 2026 | 2461 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11868 | 0.030 |
Why?
| | Cell Survival | 1 | 2018 | 1104 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2069 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1133 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2026 | 11794 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 167 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2014 | 318 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1857 | 0.020 |
Why?
| | Observer Variation | 1 | 2014 | 357 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2014 | 536 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1711 | 0.020 |
Why?
| | Brain | 1 | 2004 | 2969 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 982 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1372 | 0.010 |
Why?
| | Neurosurgery | 1 | 2004 | 41 | 0.010 |
Why?
| | Guatemala | 1 | 2004 | 343 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2014 | 6465 | 0.010 |
Why?
| | Coronary Angiography | 1 | 2004 | 328 | 0.010 |
Why?
| | Anesthesia | 1 | 2004 | 257 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2004 | 2977 | 0.010 |
Why?
|
|
Patel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|